Agents Used in Antiretroviral Therapy
Summary
- Dolutegravir is indicated in combination with other antiretroviral agents for treatment of HIV infection in adults and children aged at least 4 weeks and weighing ≥ 3 kg[FDA Dolutegravir]
- Dolutegravir is coformulated as part of 3 complete regimens for HIV treatment
- Abacavir/dolutegravir/lamivudine: indicated for treatment-naive and treatment-experienced patients
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content